| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr13_0350900 | Intergenic-Intergenic | chr13:99993878-99998602 | chr13:99341624-99346348 | 250 nt | 0.4280 |
| hsa_chr13_0351000 | Intergenic-Intergenic | chr13:99996336-99996557 | chr13:99344082-99344303 | 222 nt | 0.5000 |
| hsa_UBAC2_0009000 | Intron-Intron | chr13:99998273-99999250 | chr13:99346019-99346996 | 978 nt | 0.5092 |
A study in humans demonstrated that the circUBAC2 was significantly upregulated in the peripheral blood of myocardial infarction patients compared to healthy controls [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in human patients with ST-segment elevation myocardial infarction (STEMI) demonstrated that the circUBAC2 was identified as a differentially expressed circular RNA in peripheral blood, as confirmed in an AC16 cell model [Wang et al. DOI:10.1515/med-2023-0807].